Fresh analysis suggests that individuals who discontinue popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt conventional diet and exercise plans.
Findings released in a leading medical journal points out that while overweight people frequently drop substantial amounts of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.
"People purchasing these drugs should be informed of the danger of fast weight regain when the treatment concludes," stated researcher Dr. Susan Jebb.
Such speed of recovery means a return to pre-treatment weight in about 18 months.
Analyzing Therapies
The research, which reviewed dozens of studies involving thousands of patients, compared the effects of GLP-1 agonists with other pills.
Researchers point out that people who lose weight through dieting usually experience a less rapid weight regain—around 100 grams monthly—after stopping.
Understanding the Fast Regain
Experts believe the way of the jabs accounts for the amplified rebound.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this medication means appetite is no longer kept in check, making excessive eating far more likely."
An Ongoing Disease?
Medical guidelines suggest the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.
Many experts contend that, due to the likelihood of weight regain, the treatment should be considered ongoing.
This perspective is echoed by drug manufacturers, who note that the findings "emphasize the chronic character of excess weight," comparing it to managing diseases like high blood pressure.
User Experiences
People who have stopped the jabs describe a sudden resurgence of cravings.
"It felt as if a switch flipping and I was suddenly ravenous," said an individual.
This difficulty is compounded if individuals have not adopted permanent lifestyle or habit changes during treatment.
Significant Use
Figures show that millions of adults in the UK have used these injections in the last 12 months, with demand continuing to grow.
- Adoption is higher among females compared to men.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians caution that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic cure and long-term success likely depends on integrated lifestyle support.
